The University of Chicago Header Logo

Connection

John Fung to Animals

This is a "connection" page, showing publications John Fung has written about Animals.
Connection Strength

0.940
  1. Stromal cell-based immunotherapy in transplantation. Immunotherapy. 2011 Dec; 3(12):1471-85.
    View in: PubMed
    Score: 0.025
  2. Themes of liver transplantation. Hepatology. 2010 Jun; 51(6):1869-84.
    View in: PubMed
    Score: 0.023
  3. Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome. Liver Transpl. 2009 Nov; 15(11):1448-57.
    View in: PubMed
    Score: 0.022
  4. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells. Transpl Immunol. 2004 Jun-Jul; 13(1):15-24.
    View in: PubMed
    Score: 0.015
  5. Some morphological, growth, and genomic properties of human cells chronically infected with porcine endogenous retrovirus (PERV). Genome. 2003 Oct; 46(5):858-69.
    View in: PubMed
    Score: 0.014
  6. Bioartificial liver assist devices in support of patients with liver failure. Hepatobiliary Pancreat Dis Int. 2002 Feb; 1(1):18-25.
    View in: PubMed
    Score: 0.013
  7. Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. J Pharm Pharmacol. 2021 Aug 12; 73(9):1180-1190.
    View in: PubMed
    Score: 0.012
  8. Ischemic preconditioning: application in clinical liver transplantation. Liver Transpl. 2001 Apr; 7(4):300-1.
    View in: PubMed
    Score: 0.012
  9. Preservation injury and acute rejection of rat intestinal grafts: protection afforded by pyruvate. J Gastrointest Surg. 1999 Sep-Oct; 3(5):549-54.
    View in: PubMed
    Score: 0.011
  10. Chimerism and xenotransplantation. New concepts. Surg Clin North Am. 1999 Feb; 79(1):191-205.
    View in: PubMed
    Score: 0.010
  11. Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. Stem Cell Res. 2018 05; 29:32-41.
    View in: PubMed
    Score: 0.010
  12. Tolerance and chimerism in liver transplantation. Transplant Proc. 1997 Nov; 29(7):2817-8.
    View in: PubMed
    Score: 0.009
  13. Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors. Surg Oncol. 2017 Dec; 26(4):423-430.
    View in: PubMed
    Score: 0.009
  14. C-C Chemokine Receptor Type 2-Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants. Transplantation. 2017 08; 101(8):1793-1800.
    View in: PubMed
    Score: 0.009
  15. Quantitative assessment of the development of hepatoma in a buffalo rat model. Transplant Proc. 1997 Jun; 29(4):2263-4.
    View in: PubMed
    Score: 0.009
  16. Chimerism after organ transplantation. Curr Opin Nephrol Hypertens. 1997 May; 6(3):292-8.
    View in: PubMed
    Score: 0.009
  17. Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
    View in: PubMed
    Score: 0.009
  18. Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1168-9.
    View in: PubMed
    Score: 0.009
  19. CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal. J Biol Chem. 2017 Jan 13; 292(2):661-671.
    View in: PubMed
    Score: 0.009
  20. The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol. 1996 Sep; 80(3 Pt 2):S46-51.
    View in: PubMed
    Score: 0.009
  21. Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration. Mol Ther. 2016 09; 24(9):1665-74.
    View in: PubMed
    Score: 0.009
  22. Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage. Biomaterials. 2016 09; 102:209-19.
    View in: PubMed
    Score: 0.009
  23. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
    View in: PubMed
    Score: 0.009
  24. Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1. J Immunol. 2016 Feb 15; 196(4):1617-25.
    View in: PubMed
    Score: 0.008
  25. The bidirectional paradigm of transplant immunology. Ann N Y Acad Sci. 1995 Dec 29; 770:165-76.
    View in: PubMed
    Score: 0.008
  26. Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol. 2016 Mar; 99(3):447-54.
    View in: PubMed
    Score: 0.008
  27. Hepatic Stellate Cells Inhibit T Cells through Active TGF-ß1 from a Cell Surface-Bound Latent TGF-ß1/GARP Complex. J Immunol. 2015 Sep 15; 195(6):2648-56.
    View in: PubMed
    Score: 0.008
  28. Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice. Hepatology. 2015 Sep; 62(3):915-31.
    View in: PubMed
    Score: 0.008
  29. Liver transplantation for hepatitis B: what have we learned and what does the future hold? Liver Transpl Surg. 1995 Jul; 1(4):274-80.
    View in: PubMed
    Score: 0.008
  30. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology. 1995 May; 85(1):82-7.
    View in: PubMed
    Score: 0.008
  31. Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
    View in: PubMed
    Score: 0.008
  32. The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
    View in: PubMed
    Score: 0.008
  33. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. J Immunol. 2014 Sep 01; 193(5):2127-34.
    View in: PubMed
    Score: 0.008
  34. Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014 Aug; 20(8):987-99.
    View in: PubMed
    Score: 0.007
  35. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
    View in: PubMed
    Score: 0.007
  36. The effect of splenectomy on cardiac and liver xenografts in the nude rat. Transplant Proc. 1994 Jun; 26(3):1210.
    View in: PubMed
    Score: 0.007
  37. A new xenogeneic radiation chimera (hamster-to-rat). Transplantation. 1994 May 27; 57(10):1528-32.
    View in: PubMed
    Score: 0.007
  38. All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function. J Immunol. 2014 Jun 01; 192(11):5098-108.
    View in: PubMed
    Score: 0.007
  39. Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Transplantation. 2014 Apr 15; 97(7):740-7.
    View in: PubMed
    Score: 0.007
  40. Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model. Surg Innov. 2015 Feb; 22(1):61-9.
    View in: PubMed
    Score: 0.007
  41. Oxygen consumption predicts outcome in porcine partial liver grafts. J Surg Res. 2014 Jun 15; 189(2):335-9.
    View in: PubMed
    Score: 0.007
  42. Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
    View in: PubMed
    Score: 0.007
  43. Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant Proc. 1993 Feb; 25(1 Pt 1):444-5.
    View in: PubMed
    Score: 0.007
  44. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 2013 Mar 07; 121(10):1760-8.
    View in: PubMed
    Score: 0.007
  45. Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):959-66.
    View in: PubMed
    Score: 0.006
  46. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation. 2012 Feb 15; 93(3):272-82.
    View in: PubMed
    Score: 0.006
  47. Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis. 1992 Feb; 12(1):51-9.
    View in: PubMed
    Score: 0.006
  48. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc. 1991 Dec; 23(6):3234-5.
    View in: PubMed
    Score: 0.006
  49. Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. Transplant Proc. 1991 Dec; 23(6):3238-9.
    View in: PubMed
    Score: 0.006
  50. The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft. J Surg Res. 2012 May 01; 174(1):e37-45.
    View in: PubMed
    Score: 0.006
  51. Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology. 2011 Mar; 53(3):1007-19.
    View in: PubMed
    Score: 0.006
  52. Elevated catecholamines and hepatic artery vasospasm in porcine small-for-size liver graft. J Surg Res. 2012 May 01; 174(1):157-65.
    View in: PubMed
    Score: 0.006
  53. The role of liver stromal cells in dendritic cells development in mice. Transplant Proc. 2010 Dec; 42(10):4279-81.
    View in: PubMed
    Score: 0.006
  54. The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras. Transplant Proc. 1990 Dec; 22(6):2536-8.
    View in: PubMed
    Score: 0.006
  55. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology. 2011 Apr; 216(4):528-34.
    View in: PubMed
    Score: 0.006
  56. Glucose balance of porcine liver allograft is an important predictor of outcome. J Surg Res. 2011 Dec; 171(2):851-8.
    View in: PubMed
    Score: 0.006
  57. A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010 May; 30(4):332-7.
    View in: PubMed
    Score: 0.006
  58. Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc. 1990 Feb; 22(1):52-6.
    View in: PubMed
    Score: 0.006
  59. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 1990; 14 Suppl 1:49-63.
    View in: PubMed
    Score: 0.005
  60. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology. 2009 Dec; 50(6):1981-91.
    View in: PubMed
    Score: 0.005
  61. Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
    View in: PubMed
    Score: 0.005
  62. Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation. 2008 Dec 15; 86(11):1492-502.
    View in: PubMed
    Score: 0.005
  63. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation. 2007 Mar 15; 83(5):656-62.
    View in: PubMed
    Score: 0.005
  64. The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology. 2007 Feb; 120(2):251-60.
    View in: PubMed
    Score: 0.004
  65. Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 2007 Jan-Feb; 39(1):281-2.
    View in: PubMed
    Score: 0.004
  66. ICAM-1 expressed on hepatic stellate cells plays an important role in immune regulation. Microsurgery. 2007; 27(4):328-32.
    View in: PubMed
    Score: 0.004
  67. Cotransplanted hepatic stellate cells enhance vascularization of islet allografts. Microsurgery. 2007; 27(4):324-7.
    View in: PubMed
    Score: 0.004
  68. In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation. Liver Transpl. 2006 Dec; 12(12):1850-61.
    View in: PubMed
    Score: 0.004
  69. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology. 2006 Nov; 44(5):1171-81.
    View in: PubMed
    Score: 0.004
  70. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. J Heart Lung Transplant. 2006 Mar; 25(3):310-9.
    View in: PubMed
    Score: 0.004
  71. Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death. Microsurgery. 2006; 26(1):21-4.
    View in: PubMed
    Score: 0.004
  72. Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery. 2006; 26(1):17-20.
    View in: PubMed
    Score: 0.004
  73. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol. 2005 Jul; 131(7):429-38.
    View in: PubMed
    Score: 0.004
  74. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
    View in: PubMed
    Score: 0.004
  75. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
    View in: PubMed
    Score: 0.004
  76. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplant Proc. 2004 Jun; 36(5):1592-4.
    View in: PubMed
    Score: 0.004
  77. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
    View in: PubMed
    Score: 0.004
  78. Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl. 2004 Feb; 10(2):253-63.
    View in: PubMed
    Score: 0.004
  79. Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transpl Int. 2003 Dec; 16(12):849-56.
    View in: PubMed
    Score: 0.004
  80. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
    View in: PubMed
    Score: 0.004
  81. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes. 2003 Aug; 52(8):1976-85.
    View in: PubMed
    Score: 0.004
  82. Prolonged survival of heart allografts transduced with AAV-CTLA4Ig. Microsurgery. 2003; 23(5):489-93.
    View in: PubMed
    Score: 0.003
  83. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
    View in: PubMed
    Score: 0.003
  84. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
    View in: PubMed
    Score: 0.003
  85. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol. 2002 Sep; 37(3):340-8.
    View in: PubMed
    Score: 0.003
  86. Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. Transplant Proc. 2002 Aug; 34(5):1394-5.
    View in: PubMed
    Score: 0.003
  87. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002 Aug; 2(7):575-80.
    View in: PubMed
    Score: 0.003
  88. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002 Jul 15; 74(1):7-13.
    View in: PubMed
    Score: 0.003
  89. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem. 2002 Mar 22; 277(12):10114-20.
    View in: PubMed
    Score: 0.003
  90. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
    View in: PubMed
    Score: 0.003
  91. Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. Xenotransplantation. 2001 Aug; 8(3):213-21.
    View in: PubMed
    Score: 0.003
  92. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
    View in: PubMed
    Score: 0.003
  93. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
    View in: PubMed
    Score: 0.003
  94. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
    View in: PubMed
    Score: 0.003
  95. Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.
    View in: PubMed
    Score: 0.003
  96. Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
    View in: PubMed
    Score: 0.003
  97. Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade. Transplant Proc. 2001 Feb-Mar; 33(1-2):307.
    View in: PubMed
    Score: 0.003
  98. Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):319.
    View in: PubMed
    Score: 0.003
  99. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation. Transplant Proc. 2001 Feb-Mar; 33(1-2):382.
    View in: PubMed
    Score: 0.003
  100. Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
    View in: PubMed
    Score: 0.003
  101. Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):604.
    View in: PubMed
    Score: 0.003
  102. Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species. Transplant Proc. 2001 Feb-Mar; 33(1-2):710-1.
    View in: PubMed
    Score: 0.003
  103. Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):778.
    View in: PubMed
    Score: 0.003
  104. Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system. Transplant Proc. 2001 Feb-Mar; 33(1-2):1976.
    View in: PubMed
    Score: 0.003
  105. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
    View in: PubMed
    Score: 0.003
  106. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. Transplant Proc. 2000 Dec; 32(8):2710-2.
    View in: PubMed
    Score: 0.003
  107. Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene. Transplantation. 2000 Nov 15; 70(9):1275-83.
    View in: PubMed
    Score: 0.003
  108. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
    View in: PubMed
    Score: 0.003
  109. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem. 2000 Sep 08; 275(36):28083-92.
    View in: PubMed
    Score: 0.003
  110. Ischemia/reperfusion injury induces chronic changes in the small bowel. Transplant Proc. 2000 Sep; 32(6):1315.
    View in: PubMed
    Score: 0.003
  111. Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. Hepatology. 2000 Aug; 32(2):256-67.
    View in: PubMed
    Score: 0.003
  112. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
    View in: PubMed
    Score: 0.003
  113. Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. Transplant Proc. 2000 Aug; 32(5):1036-7.
    View in: PubMed
    Score: 0.003
  114. Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. Transplant Proc. 2000 Aug; 32(5):1109.
    View in: PubMed
    Score: 0.003
  115. Loss of serum bicarbonate after discordant liver xenotransplantation. Transplant Proc. 2000 Aug; 32(5):1110.
    View in: PubMed
    Score: 0.003
  116. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol. 2000 May; 156(5):1627-39.
    View in: PubMed
    Score: 0.003
  117. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther. 2000 May; 1(5 Pt 1):430-7.
    View in: PubMed
    Score: 0.003
  118. Serum protein immunogenicity: implications for liver xenografting. Electrophoresis. 2000 Mar; 21(5):965-75.
    View in: PubMed
    Score: 0.003
  119. Maturation of B-cell clones. Prog Clin Biol Res. 1980; 42:203-14.
    View in: PubMed
    Score: 0.003
  120. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
    View in: PubMed
    Score: 0.003
  121. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
    View in: PubMed
    Score: 0.003
  122. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.
    View in: PubMed
    Score: 0.003
  123. Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat. Xenotransplantation. 1999 May; 6(2):117-22.
    View in: PubMed
    Score: 0.003
  124. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
    View in: PubMed
    Score: 0.003
  125. Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses. Transplant Proc. 1999 Feb-Mar; 31(1-2):115.
    View in: PubMed
    Score: 0.003
  126. Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
    View in: PubMed
    Score: 0.003
  127. Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline. Transplant Proc. 1999 Feb-Mar; 31(1-2):575-6.
    View in: PubMed
    Score: 0.003
  128. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Transplant Proc. 1999 Feb-Mar; 31(1-2):646-7.
    View in: PubMed
    Score: 0.003
  129. Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc. 1999 Feb-Mar; 31(1-2):784.
    View in: PubMed
    Score: 0.003
  130. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
    View in: PubMed
    Score: 0.003
  131. Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. Transplant Proc. 1999 Feb-Mar; 31(1-2):845.
    View in: PubMed
    Score: 0.003
  132. Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys. Transplant Proc. 1999 Feb-Mar; 31(1-2):1033.
    View in: PubMed
    Score: 0.003
  133. Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 1999 Feb-Mar; 31(1-2):1195.
    View in: PubMed
    Score: 0.003
  134. Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc. 1999 Feb-Mar; 31(1-2):1242-3.
    View in: PubMed
    Score: 0.003
  135. Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
    View in: PubMed
    Score: 0.003
  136. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
    View in: PubMed
    Score: 0.003
  137. Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation. 1998 Dec 15; 66(11):1545-51.
    View in: PubMed
    Score: 0.003
  138. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
    View in: PubMed
    Score: 0.002
  139. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc. 1998 Jun; 30(4):941-2.
    View in: PubMed
    Score: 0.002
  140. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Transplant Proc. 1998 Jun; 30(4):1091-2.
    View in: PubMed
    Score: 0.002
  141. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
    View in: PubMed
    Score: 0.002
  142. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation. 1997 Dec 27; 64(12):1838-43.
    View in: PubMed
    Score: 0.002
  143. Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. Transplantation. 1997 Dec 15; 64(11):1595-8.
    View in: PubMed
    Score: 0.002
  144. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
    View in: PubMed
    Score: 0.002
  145. The immunolymphatic theory of chronic rejection. Transplant Proc. 1997 Sep; 29(6):2615-6.
    View in: PubMed
    Score: 0.002
  146. Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997 Aug 27; 64(4):559-65.
    View in: PubMed
    Score: 0.002
  147. Early recipient-donor switch of the complement type after liver xenotransplantation. Immunol Invest. 1997 Aug-Dec; 26(5-7):589-600.
    View in: PubMed
    Score: 0.002
  148. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
    View in: PubMed
    Score: 0.002
  149. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
    View in: PubMed
    Score: 0.002
  150. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1081-2.
    View in: PubMed
    Score: 0.002
  151. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
    View in: PubMed
    Score: 0.002
  152. Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc. 1997 Feb-Mar; 29(1-2):700.
    View in: PubMed
    Score: 0.002
  153. Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):928-9.
    View in: PubMed
    Score: 0.002
  154. Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant. 1997; 2(2):27-44.
    View in: PubMed
    Score: 0.002
  155. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation. 1996 Dec 27; 62(12):1709-14.
    View in: PubMed
    Score: 0.002
  156. Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc. 1996 Oct; 28(5):2455.
    View in: PubMed
    Score: 0.002
  157. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
    View in: PubMed
    Score: 0.002
  158. Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation. 1996 Jun 27; 61(12):1730-5.
    View in: PubMed
    Score: 0.002
  159. Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. Transplantation. 1996 Apr 27; 61(8):1228-33.
    View in: PubMed
    Score: 0.002
  160. The antigenicity of serum proteins and their role in xenograft rejection. Transplant Proc. 1996 Apr; 28(2):669-70.
    View in: PubMed
    Score: 0.002
  161. Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. Transplant Proc. 1996 Apr; 28(2):696-7.
    View in: PubMed
    Score: 0.002
  162. Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Transplant Proc. 1996 Apr; 28(2):732.
    View in: PubMed
    Score: 0.002
  163. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):733-4.
    View in: PubMed
    Score: 0.002
  164. Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. Transplant Proc. 1996 Apr; 28(2):735.
    View in: PubMed
    Score: 0.002
  165. Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. Transplant Proc. 1996 Apr; 28(2):736-7.
    View in: PubMed
    Score: 0.002
  166. Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. Transplant Proc. 1996 Apr; 28(2):738-9.
    View in: PubMed
    Score: 0.002
  167. Small bowel transplantation: current progress and clinical application. Hepatogastroenterology. 1996 Mar-Apr; 43(8):363-76.
    View in: PubMed
    Score: 0.002
  168. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest. 1996 Jan 01; 97(1):217-25.
    View in: PubMed
    Score: 0.002
  169. Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
    View in: PubMed
    Score: 0.002
  170. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
    View in: PubMed
    Score: 0.002
  171. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27; 60(2):158-71.
    View in: PubMed
    Score: 0.002
  172. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
    View in: PubMed
    Score: 0.002
  173. Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. Transplant Proc. 1995 Feb; 27(1):277.
    View in: PubMed
    Score: 0.002
  174. Mechanisms of protection from humoral rejection by a xenografted liver. Transplant Proc. 1995 Feb; 27(1):300-2.
    View in: PubMed
    Score: 0.002
  175. Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
    View in: PubMed
    Score: 0.002
  176. The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc. 1995 Feb; 27(1):270.
    View in: PubMed
    Score: 0.002
  177. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
    View in: PubMed
    Score: 0.002
  178. The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp. 1995; 24:341-54.
    View in: PubMed
    Score: 0.002
  179. A simplified method for growing dendritic cells from rat bone marrow. Adv Exp Med Biol. 1995; 378:53-5.
    View in: PubMed
    Score: 0.002
  180. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
    View in: PubMed
    Score: 0.002
  181. Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
    View in: PubMed
    Score: 0.002
  182. Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. Transplant Proc. 1994 Jun; 26(3):1208.
    View in: PubMed
    Score: 0.002
  183. Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. Transplant Proc. 1994 Jun; 26(3):1255.
    View in: PubMed
    Score: 0.002
  184. Prospects of clinical xenotransplantation. Transplant Proc. 1994 Jun; 26(3):1082-8.
    View in: PubMed
    Score: 0.002
  185. Metabolic changes in the recipient after successful liver xenotransplantation in the rat. Transplant Proc. 1994 Jun; 26(3):1207.
    View in: PubMed
    Score: 0.002
  186. Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection. Transplant Proc. 1994 Jun; 26(3):1288-9.
    View in: PubMed
    Score: 0.002
  187. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr; 19(4):916-24.
    View in: PubMed
    Score: 0.002
  188. Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation. 1994 Mar 27; 57(6):918-22.
    View in: PubMed
    Score: 0.002
  189. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec; 25(6):3337-44.
    View in: PubMed
    Score: 0.002
  190. Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival. Ann N Y Acad Sci. 1993 Nov 30; 696:227-34.
    View in: PubMed
    Score: 0.002
  191. Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation. 1993 Oct; 56(4):905-11.
    View in: PubMed
    Score: 0.002
  192. Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
    View in: PubMed
    Score: 0.002
  193. Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation. 1993 Aug; 56(2):489-90.
    View in: PubMed
    Score: 0.002
  194. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol. 1993 Jul; 143(1):85-98.
    View in: PubMed
    Score: 0.002
  195. Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant. 1993 Jul-Aug; 2(4):345-53.
    View in: PubMed
    Score: 0.002
  196. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol. 1993 May; 142(5):1383-91.
    View in: PubMed
    Score: 0.002
  197. Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation. 1993 Mar; 55(3):659-61.
    View in: PubMed
    Score: 0.002
  198. Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):414-5.
    View in: PubMed
    Score: 0.002
  199. Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 1):647-8.
    View in: PubMed
    Score: 0.002
  200. Xenoreactivity in mouse + rat-->mouse chimeras. Transplant Proc. 1993 Feb; 25(1 Pt 1):455-6.
    View in: PubMed
    Score: 0.002
  201. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc. 1993 Feb; 25(1 Pt 1):704-5.
    View in: PubMed
    Score: 0.002
  202. Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc. 1992 Aug; 24(4):1403-5.
    View in: PubMed
    Score: 0.002
  203. Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc. 1992 Aug; 24(4):1605-6.
    View in: PubMed
    Score: 0.002
  204. Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. Transplant Proc. 1992 Jun; 24(3):1042.
    View in: PubMed
    Score: 0.002
  205. Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc. 1992 Jun; 24(3):1143-4.
    View in: PubMed
    Score: 0.002
  206. Survival of human hepatocellular aggregates in athymic mice. Transplant Proc. 1992 Jun; 24(3):986.
    View in: PubMed
    Score: 0.002
  207. Interaction between FK 506 and cyclosporine in dogs. Transplant Proc. 1991 Dec; 23(6):2797-9.
    View in: PubMed
    Score: 0.002
  208. The pharmacodynamics of pentobarbital following FK 506 therapy. Transplant Proc. 1991 Dec; 23(6):2800-1.
    View in: PubMed
    Score: 0.002
  209. Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc. 1991 Dec; 23(6):2873-4.
    View in: PubMed
    Score: 0.002
  210. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc. 1991 Dec; 23(6):2957-8.
    View in: PubMed
    Score: 0.002
  211. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc. 1991 Dec; 23(6):3232-3.
    View in: PubMed
    Score: 0.002
  212. Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3269-71.
    View in: PubMed
    Score: 0.002
  213. Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation. 1991 Oct; 52(4):590-4.
    View in: PubMed
    Score: 0.002
  214. Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep; 52(3):562-4.
    View in: PubMed
    Score: 0.002
  215. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery. 1991 Aug; 110(2):357-63; discussion 363-4.
    View in: PubMed
    Score: 0.002
  216. Effects of in vivo treatment with FK506 on natural killer cells in rats. Transplantation. 1991 Apr; 51(4):913-5.
    View in: PubMed
    Score: 0.001
  217. Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol. 1991 Mar; 138(3):609-18.
    View in: PubMed
    Score: 0.001
  218. Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc. 1991 Feb; 23(1 Pt 2):914-9.
    View in: PubMed
    Score: 0.001
  219. Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc. 1991 Feb; 23(1 Pt 1):705-6.
    View in: PubMed
    Score: 0.001
  220. Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
    View in: PubMed
    Score: 0.001
  221. Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation. 1990 Aug; 50(2):186-9.
    View in: PubMed
    Score: 0.001
  222. Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc. 1990 Feb; 22(1):93-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.